Search
for
Sort by
Research 30 of 1000+
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Alopecia areata following COVID-19 vaccine: a systematic review
- Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
- Alopecia Areata after COVID-19 Vaccines
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Medication-induced hair loss: An update
- BH07 The socioeconomic burden of alopecia areata
- MCAS, POTS, Dysautonomia, and “Genetic Disorders” — Long COVID Observations
- BH23 Mind the gap! Navigating barriers to care access for patients with alopecia areata in the UK: a qualitative interview study
- Guest Editor's Note
- How coronavirus disease 2019 vaccination affect the level of vitamin D in serum and hair?
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- First drug for severe alopecia recommended by NICE could benefit 14,000 patients
- Side Effects of COVID-19 Vaccination Among Medical Students in Bangladesh: A Cross-Sectional Study
- Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Updated Integrated Efficacy Analysis of Ritlecitinib Up to 3 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Marie Antoinette syndrome following COVID‐19 vaccination
- Equity research
- A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine
- Bacillus Calmette-Guerin (BCG) Site Reaction After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production
- Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production
- Diphenyl ethers as androgen receptor antagonists for the topical suppression of sebum production
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- Ritlecitinib: First Approval